Identification | Back Directory | [Name]
5-BROMO-2-METHOXY-3-NITRO-PYRIDINE | [CAS]
152684-30-5 | [Synonyms]
2-METHOXY-3-NITRO-5-BROMOPYRIDINE 5-BROMO-2-METHOXY-3-NITRO-PYRIDINE Pyridine,5-bromo-2-methoxy-3-nitro- 5-Bromo-2-methoxy-3-nitropyridine > 5-BroMo-2-Methoxy-3-nitropyridine, 97+% 5-BROMO-2-METHOXY-3-NITRO-PYRIDINE ISO 9001:2015 REACH | [Molecular Formula]
C6H5BrN2O3 | [MDL Number]
MFCD07374968 | [MOL File]
152684-30-5.mol | [Molecular Weight]
233.02 |
Chemical Properties | Back Directory | [Melting point ]
88.0 to 92.0 °C | [Boiling point ]
282.0±35.0 °C(Predicted) | [density ]
1.730±0.06 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,Room Temperature | [form ]
powder to crystal | [pka]
-2.99±0.20(Predicted) | [color ]
Light yellow to Brown to Dark green | [InChI]
InChI=1S/C6H5BrN2O3/c1-12-6-5(9(10)11)2-4(7)3-8-6/h2-3H,1H3 | [InChIKey]
YRVHFGOAEVWBNS-UHFFFAOYSA-N | [SMILES]
C1(OC)=NC=C(Br)C=C1[N+]([O-])=O |
Hazard Information | Back Directory | [Synthesis]
Sodium metal (2.90 g, 126.4 mmol) was added to the cooled methanol (50.0 mL) in batches, and the mixture was slowly warmed to room temperature with continuous stirring until the sodium was completely dissolved. Subsequently, the solution was added to 2-chloro-3-nitro-5-bromopyridine (10.0 g, 42.12 mmol, Shanghai Longsheng Chemical, China) suspended in methanol (100 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 1 hour, then warmed up to room temperature and continued stirring for 16 hours. Upon completion of the reaction, the mixture was concentrated to about 80 mL and the reaction was quenched with deionized water (100 mL). The precipitate was collected by filtration, washed with deionized water (50 mL x 2) and dried under an infrared lamp to afford 5-bromo-2-methoxy-3-nitropyridine as a light yellow solid (9.62 g, 98% yield). Mass spectrum (ESI, positive ion mode) m/z: 233.0 [M + H]+. | [References]
[1] Patent: US2014/134133, 2014, A1. Location in patent: Paragraph 0384 [2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 15, p. 3534 - 3541 [3] ACS Medicinal Chemistry Letters, 2017, vol. 8, # 7, p. 737 - 741 [4] Patent: WO2014/22128, 2014, A1. Location in patent: Paragraph 0149 |
|
|